Thermo Fisher Scientific Inc (NYSE: TMO) started the day on Wednesday, with a price decrease of -1.04% at $528.87, before settling in for the price of $534.42 at the close. Taking a more long-term approach, TMO posted a 52-week range of $487.06-$627.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 12.53%. Meanwhile, its Annual Earning per share during the time was 16.37%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 0.67%. This publicly-traded company’s shares outstanding now amounts to $382.50 million, simultaneously with a float of $381.97 million. The organization now has a market capitalization sitting at $202.29 billion. At the time of writing, stock’s 50-day Moving Average stood at $563.34, while the 200-day Moving Average is $576.72.
Thermo Fisher Scientific Inc (TMO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Thermo Fisher Scientific Inc’s current insider ownership accounts for 0.14%, in contrast to 90.08% institutional ownership. According to the most recent insider trade that took place on Dec 03 ’24, this organization’s Chairman & CEO sold 10,000 shares at the rate of 532.20, making the entire transaction reach 5,321,955 in total value, affecting insider ownership by 101,192. Preceding that transaction, on Dec 02 ’24, Company’s Chairman & CEO sold 10,000 for 530.26, making the whole transaction’s value amount to 5,302,604. This particular insider is now the holder of 111,192 in total.
Thermo Fisher Scientific Inc (TMO) Earnings and Revenue Records
Thermo Fisher Scientific Inc’s EPS increase for this current 12-month fiscal period is 0.67% and is forecasted to reach 23.52 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.87% through the next 5 years, which can be compared against the 16.37% growth it accomplished over the previous five years trading on the market.
Thermo Fisher Scientific Inc (NYSE: TMO) Trading Performance Indicators
Let’s observe the current performance indicators for Thermo Fisher Scientific Inc (TMO). It’s Quick Ratio in the last reported quarter now stands at 1.26. The Stock has managed to achieve an average true range (ATR) of 11.12. Alongside those numbers, its PE Ratio stands at $33.17, and its Beta score is 0.77. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.77. Similarly, its price to free cash flow for trailing twelve months is now 26.02.
In the same vein, TMO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 15.95, a figure that is expected to reach 5.94 in the next quarter, and analysts are predicting that it will be 23.52 at the market close of one year from today.
Technical Analysis of Thermo Fisher Scientific Inc (TMO)
If we take a close look at the recent performances of Thermo Fisher Scientific Inc (NYSE: TMO), its last 5-days Average volume was 2.57 million that shows progress from its year to date volume of 1.53 million. During the previous 9 days, stock’s Stochastic %D was recorded 85.82% While, its Average True Range was 10.90.
Raw Stochastic average of Thermo Fisher Scientific Inc (TMO) in the period of the previous 100 days is set at 26.43%, which indicates a major fall in contrast to 72.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 24.31% that was higher than 21.55% volatility it exhibited in the past 100-days period.